This page lists the SEC filings reported by AUSTIN JOSIAH T.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2014-09-12 | AUSTIN JOSIAH T | Protea Biosciences Group, Inc. | - | 23.8% | EDGAR |
| SC 13D/A | 2014-08-19 | AUSTIN JOSIAH T | Protea Biosciences Group, Inc. | 18,101,951 | 23.3% | EDGAR |
| SC 13D/A | 2014-07-15 | AUSTIN JOSIAH T | Protea Biosciences Group, Inc. | 17,607,405 | 22.9% | EDGAR |
| SC 13D | 2014-07-07 | AUSTIN JOSIAH T | MRI INTERVENTIONS, INC. | 3,381,456 | 5.6% | EDGAR |
| SC 13D/A | 2014-07-03 | AUSTIN JOSIAH T | Protea Biosciences Group, Inc. | 17,245,939 | 22.6% | EDGAR |
| SC 13D/A | 2014-06-09 | AUSTIN JOSIAH T | Protea Biosciences Group, Inc. | 16,591,393 | 22.0% | EDGAR |
| SC 13D/A | 2014-06-04 | AUSTIN JOSIAH T | Protea Biosciences Group, Inc. | 16,155,029 | 21.5% | EDGAR |
| SC 13D/A | 2014-05-16 | AUSTIN JOSIAH T | Protea Biosciences Group, Inc. | 15,645,938 | 21.0% | EDGAR |
| SC 13D/A | 2014-05-13 | AUSTIN JOSIAH T | Protea Biosciences Group, Inc. | - | 20.8% | EDGAR |
| SC 13D/A | 2014-04-04 | AUSTIN JOSIAH T | Protea Biosciences Group, Inc. | 15,051,744 | 20.4% | EDGAR |
| SC 13D/A | 2014-02-14 | AUSTIN JOSIAH T | Protea Biosciences Group, Inc. | 14,484,695 | 19.8% | EDGAR |
| SC 13D/A | 2013-11-25 | AUSTIN JOSIAH T | NOVOGEN LTD | 12,269,033 | 7.7% | EDGAR |
| SC 13D/A | 2013-11-21 | AUSTIN JOSIAH T | Chelsea Therapeutics International, Ltd. | 3,843,168 | 4.9% | EDGAR |
| SC 13D/A | 2013-11-04 | AUSTIN JOSIAH T | NOVOGEN LTD | 14,773,408 | 10.2% | EDGAR |
| SC 13D/A | 2013-10-22 | AUSTIN JOSIAH T | NOVOGEN LTD | 17,935,908 | 12.4% | EDGAR |
| SC 13D/A | 2013-10-01 | AUSTIN JOSIAH T | Protea Biosciences Group, Inc. | 10,148,999 | 18.2% | EDGAR |
| SC 13D/A | 2013-09-17 | AUSTIN JOSIAH T | Protea Biosciences Group, Inc. | 9,323,999 | 17.0% | EDGAR |
| SC 13D/A | 2013-09-03 | AUSTIN JOSIAH T | GOODRICH PETROLEUM CORP | 1,983,390 | 5.4% | EDGAR |
| SC 13D/A | 2013-06-17 | AUSTIN JOSIAH T | Chelsea Therapeutics International, Ltd. | 4,642,166 | 6.9% | EDGAR |
| SC 13D/A | 2013-06-14 | AUSTIN JOSIAH T | Protea Biosciences Group, Inc. | 7,061,044 | 15.6% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.